ABOUT US  |  CAREERS  |  CONTACT US  |  LOGIN  |  SITE MAP  

The following table includes recommendations which have been developed or endorsed by various groups. Over the years the BC transfusion medicine community has developed several BC specific recommendations. This work has involved the leadership of the Transfusion Medicine Advisory Group (TMAG), specialized physician experts, the Technical Resource Group (TRG) and the Nursing Resource Group (NRG).

In addition, the National Advisory Committee for Blood and Blood Products (NAC) has developed recommendations, as well as endorsed recommendations of other national or international organizations, some of which are listed in the table below. This list is not comprehensive and NAC continues to develop new guidelines and recommendations, and endorse others. Users are encouraged to visit the NAC website.

For more resources, visit the Additional Resources page. 

 Recommendations
BC Developed NAC Developed NAC Endorsed
Blood Components
NAC Statement on the Provision of Rare Red Blood Cells (Nov 2025)
NAC: Utilization and Inventory Management of Group O RH(D)- Negative Red Cells (Sept 2025)
NAC: Appropriateness of use of CMV Seronegative vs. CMV Safe Product (July 2025)
Recommendations for Red Blood Cell Selection for Transfusion in Sickle Cell Disease - Section 9.6 (Oct 2023) ✓     

Red Blood Cell Transfusion: 2023 AABB International Guidelines (Oct 2023)

Note: NAC Endorsement with Caveats (May, 2024)

   
NAC: Recommendations for Use of Irradiated Blood Components (Apr 2023)    
Transfusion of Platelets to Adults - Section 5.2 (Dec 2019) ✓     
Plasma Protein and Related Products (PPRPs)
Immune Globulin
Guidelines for SCIG Home Infusion Programs (Jan 2023)  ✓    
IVIG Utilization Management Program Recommendations (July 2019)  ✓    
PBCO Ig Rheumatology Panel     
Guide for Treatment of Neurology Conditions with Ig (Feb 2025)    
Neurology - PNS Conditions (Feb 2025)    
Neurology - CNS Conditions (Feb 2025)    
PID Diagnostic and Treatment Recommendations (May 2018)    
SID Recommendations (Jan 2024)    
Other PPRPs
A1-PI (Glassia) BC Recommendations (Aug 2024)     
ICTMG: Intravenous Albumin (Aug 2024)    
Transfusion Medicine Processes and Protocols
TMAG Position Statement on Requirements of Patient Support Programs (Feb 2026)
Infection Prevention and Control Considerations for Return of Blood Components and Products to Inventory (Nov 2025)
TMAG Position Statement on Blood Prescribing Privileges (Sep 2025)    

PHSA: Clinical Practice Guideline for the Management of Trauma-Based Massive Hemorrhage (Apr 2024)

Note: NAC Endorsement with Caveats (Nov 2025) for the European Guideline referenced in this CPG. 

   
Cross-Health Authority Transfusion Reaction Recommendation (Mar 2024) ✓     
NAC: Recommendations for the Notification of Recipients of a Blood Component Recall (July 2023)